Sponsor Pipeline

ITM Solucin GmbH Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04919226 Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive… Neuroendocrine Tumors Active, Not Recruiting
NCT03049189 Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients Neuroendocrine Tumors Active, Not Recruiting
Phase 1
NCT06441331 Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177… Somatostatin Receptor Positive Recruiting
Disease Areas
Sarcoma (1)
Get alerts when ITM Solucin GmbH's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free